ProfileGDS4718 / 222608_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 79% 38% 23% 72% 47% 95% 94% 66% 32% 82% 70% 51% 94% 96% 95% 88% 71% 94% 92% 84% 74% 77% 79% 74% 87% 89% 46% 90% 75% 92% 93% 90% 21% 65% 82% 92% 95% 34% 53% 52% 68% 94% 76% 92% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]7.7268979
GSM549102patient 115, normal, homogenized [OPG study]4.9113638
GSM549104patient 119, normal, homogenized [OPG study]4.2450523
GSM549108patient 138, normal, homogenized [OPG study]6.9756972
GSM549119patient 077, normal, homogenized [OPG study]5.3619747
GSM549133patient 032, cancer, homogenized [OPG study]10.310295
GSM549139patient 042, cancer, homogenized [OPG study]9.9914594
GSM549099patient 107, normal, homogenized [OPG study]6.555666
GSM549109patient 139, normal, homogenized [OPG study]4.6607132
GSM549110patient 046, normal, homogenized [OPG study]8.0757882
GSM549114patient 063, normal, homogenized [OPG study]6.8201870
GSM549122patient 082, normal, homogenized [OPG study]5.54751
GSM549134patient 033, cancer, homogenized [OPG study]10.01294
GSM549136patient 036, cancer, homogenized [OPG study]10.52396
GSM549140patient 044, cancer, homogenized [OPG study]10.140395
GSM549111patient 047, normal, homogenized [OPG study]8.9480588
GSM549113patient 057, normal, homogenized [OPG study]6.9968171
GSM549132patient 031, cancer, homogenized [OPG study]9.9388294
GSM549137patient 038, cancer, homogenized [OPG study]9.465692
GSM549142patient 047, cancer, homogenized [OPG study]8.0123184
GSM549100patient 110, normal, homogenized [OPG study]7.1808874
GSM549107patient 135, normal, homogenized [OPG study]7.5026677
GSM549115patient 068, normal, homogenized [OPG study]7.831379
GSM549116patient 072, normal, homogenized [OPG study]7.295574
GSM549120patient 078, normal, homogenized [OPG study]8.7886787
GSM549131patient 030, cancer, homogenized [OPG study]9.1421689
GSM549118patient 074, normal, homogenized [OPG study]5.2648446
GSM549129patient 027, cancer, homogenized [OPG study]9.0663290
GSM549123patient 088, normal, homogenized [OPG study]7.3805675
GSM549124patient 006, cancer, homogenized [OPG study]9.4734392
GSM549126patient 015, cancer, homogenized [OPG study]9.635493
GSM549128patient 025, cancer, homogenized [OPG study]9.2467990
GSM549103patient 117, normal, homogenized [OPG study]4.2430321
GSM549117patient 073, normal, homogenized [OPG study]6.4125165
GSM549138patient 041, cancer, homogenized [OPG study]8.0826682
GSM549141patient 045, cancer, homogenized [OPG study]9.5496992
GSM549130patient 028, cancer, homogenized [OPG study]10.031995
GSM549101patient 111, normal, homogenized [OPG study]4.7529934
GSM549105patient 128, normal, homogenized [OPG study]5.7068853
GSM549106patient 134, normal, homogenized [OPG study]5.5886452
GSM549112patient 048, normal, homogenized [OPG study]6.6942768
GSM549125patient 011, cancer, homogenized [OPG study]9.8233494
GSM549127patient 024, cancer, homogenized [OPG study]7.5214376
GSM549135patient 035, cancer, homogenized [OPG study]9.6007492